Skip to content

UnitedHealth Group UNH Optum Rx — Gain On Portfolio Actions

Similar metrics at other companies

Conduent Incorporated logo
CNDTGain (Loss) On Divestitures And Sales Of Assets
-$500K-100%
STR
STRSReal Estate Operations — Gain (Loss) on Disposition of Assets
$0
Mosaic logo
MOSCorporate, Eliminations and Other — Gain (Loss) on Disposition of Assets
$0
Capital Southwest logo
CSWCGain (Loss), Investment and Derivative, Operating, after Tax
-$7.13M+30.6%
Richardson Electronics logo
RELLGain Loss On Disposal Of Healthcare Assets And Other Charges
$1.28M
DeFi Development Corp. logo
DFDVReal estate platform — Gain (Loss) on Disposition of Assets
-$489.5K

Other financials

Income statement

See full
Revenue$111.72B+2.0%
Gross profit$98.9B+1.8%
Operating income$9.0B-1.4%
Net income$6.3B-0.2%
EPS (diluted)$6.90+0.7%

Balance sheet

See full
Cash & equivalents$28.0B-8.8%
Total debt$77.9B-4.1%
Total equity$103.90B+3.1%
Total assets$312.64B+0.9%

Cash flow

See full
Operating cash flow$8.9B+63.3%
CapEx$763.0M-15.0%
Free cash flow$8.1B+78.8%

Valuation

See full
Market cap$382.09B+49.3%
Enterprise value$432.01B+40.9%
P/E31.7×+19.7×
P/S0.9×+0.2×

Profitability

See full
Gross margin88.6%+0.4pp
Operating margin4.2%-4.0pp
Net margin2.7%-2.7pp
FCF margin4.4%-1.7pp

Returns & leverage

See full
Return on equity11.8%-11.1pp
Debt / equity0.8×-0.1×
Current ratio0.8×-0.1×

Where this comes from

Reported directly by UnitedHealth Group in its filing.

Tagged under the XBRL concept unh:GainOnPortfolioActions.

The official record: UnitedHealth Group’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about UnitedHealth Group's optum rx — gain on portfolio actions.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is UnitedHealth Group's optum rx — gain on portfolio actions?
UnitedHealth Group (UNH) reported optum rx — gain on portfolio actions of $8M in Q1 2026.
What does optum rx — gain on portfolio actions mean?
This metric represents the net financial impact resulting from strategic portfolio adjustments, such as the divestiture of business units, restructuring of assets, or other non-recurring portfolio-level actions within the pharmacy care services segment. It captures gains or losses that are distinct from core operating activities, reflecting management's efforts to optimize the business mix and capital structure. This figure is critical for investors to isolate the impact of one-time strategic decisions from the underlying operational performance of the pharmacy benefit management business.